Intra-Articular Transplantation of Allogeneic BMMSCs Rehabilitates Cartilage Injury of Antigen-Induced Arthritis

Tissue Engineering - Part A

Volumn 21, Issue 21-22, 2015, Pages 2733-2743

  Liu, He ^a   Ding, Jianxun ^b   Wang, Chenyu ^c   Wang, Jincheng ^a   Wang, Yinan ^d   Yang, Modi ^a   Jia, Yunlong ^a   Zhang, Yanbo ^a   Chang, Fei ^a   Li, Rui ^a   Chen, Xuesi ^b  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^c Hallym University   (South Korea)

^d THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELL CULTURE; CELL DEATH; DEFECTS; DISEASES; REPAIR; STEM CELLS; SYNCHROTRONS;

ARTICULAR CARTILAGES; BONE MARROW MESENCHYMAL STEM CELLS; INFLAMMATORY CONDITIONS; INFLAMMATORY REACTION; OSTEOCHONDRAL DEFECTS; PROTECTION CAPABILITIES; RHEUMATOID ARTHRITIS; TUMOR NECROSIS FACTOR ALPHA;

CARTILAGE;

INTERLEUKIN 1BETA; INTERLEUKIN 6; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA; ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ARTICULAR CARTILAGE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARTILAGE INJURY; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; RHEUMATOID ARTHRITIS; ANIMAL; ARTHRITIS; ARTHRITIS, RHEUMATOID; BONE MARROW CELL; CELL CULTURE; CHEMICALLY INDUCED; CHONDROGENESIS; DRUG EFFECTS; IMMUNOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; MESENCHYMAL STROMA CELL; PATHOLOGY; PROCEDURES; RABBIT; TREATMENT OUTCOME;

ANIMALS; ANTIGENS; ARTHRITIS; ARTHRITIS, RHEUMATOID; BONE MARROW CELLS; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROGENESIS; INJECTIONS, INTRA-ARTERIAL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RABBITS; TREATMENT OUTCOME;

EID: 84946911777     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2014.0666     Document Type: Article

References (44)

1. Xi, H., Cun, D., Xiang, R., Guan, Y., Zhang, Y., Li, Y., and Fang, L. Intra-articular drug delivery from an optimized topical patch containing teriflunomide and lornoxicam for rheumatoid arthritis treatment: does the topical patch really enhance a local treatment? J Control Release 169, 73, 2013.
2. Siebert, S., Tsoukas, A., Robertson, J., and McInnes, I. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases. Pharmacol Rev 67, 280, 2015.
3. Choy, E.H. Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis. Clin Exp Rheumatol 27, 510, 2009.
4. Leandro, M.J., and Becerra-Fernandez, E. B-cell therapies in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 25, 535, 2011.
5. Foldager, C.B. Advances in autologous chondrocyte implantation and related techniques for cartilage repair. Dan Med J 60, B4600, 2013.
6. Qi, Y., Feng, G., and Yan, W. Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis. Mol Biol Rep 39, 5683, 2012.
7. Olee, T., Grogan, S.P., Lotz, M.K., Colwell, C.W., Jr., D'Lima, D.D., and Snyder, E.Y. Repair of cartilage defects in arthritic tissue with differentiated human embryonic stem cells. Tissue Eng Part A 20, 683, 2014.
8. Tsumaki, N., Okada, M., and Yamashita, A. iPS cell technologies and cartilage regeneration. Bone 12, S8756, 2014.
9. Soleymaninejadian, E., Pramanik, K., and Samadian, E. Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am J Reprod Immunol 67, 1, 2012.
10. Shi, M., Liu, Z.W., and Wang, F.S. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 164, 1, 2011.
11. Sanchez-Berna, I., Santiago-Diaz, C., and Jimenez-Alonso, J. Immunomodulatory properties of stem mesenchymal cells in autoimmune diseases. Med Clin (Barc) 14, Suppl 25, ii 82, 2014.
12. Liu, Z., Wang, W., Gao, J., Zhou, H., and Zhang, Y. Isolation, culture, and induced multiple differentiation of Mongolian sheep bone marrow-derived mesenchymal stem cells. In Vitro Cell Dev Biol Anim 50, 464, 2014.
13. Handl, M., Trc, T., Hanus, M., Stastny, E., Fricova-Poulova, M., Neuwirth, J., et al. Therapy of severe chondral defects of the patella by autologous chondrocyte implantation. Acta Chir Orthop Traumatol Cech 73, 373, 2006.
14. Visna, P., Pasa, L., Hart, R., Kocis, J., Cizmar, I., and Adler, J. Treatment of deep chondral defects of the knee using autologous chondrocytes cultured on a support - results after one year. Acta Chir Orthop Traumatol Cech 70, 356, 2003.
15. Xie, X.T., Wang, Y., Zhao, C.J., Guo, S.C., Liu, S., Jia, W.T., et al. Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials 33, 7008, 2012.
16. Chang, F., Ishii, T., Yanai, T., Mishima, H., Akaogi, H., Ogawa, T., and Ochiai, N. Repair of large full-thickness articular cartilage defects by transplantation of autologous uncultured bone-marrow-derived mononuclear cells. J Orthop Res 26, 18, 2008.
17. Augello, A., Tasso, R., Negrini, S.M., Cancedda, R., and Pennesi, G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 56, 1175, 2007.
18. Mao, F., Xu, W.R., Qian, H., Zhu, W., Yan, Y.M., Shao, Q.X., and Xu, H.X. Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis. Inflamm Res 59, 219, 2010.
19. Keerthi, N., Chimutengwende-Gordon, M., Sanghani, A., and Khan, W. The potential of stem cell therapy for osteoarthritis and rheumatoid arthritis. Curr Stem Cell Res Ther 8, 444, 2013.
20. Gonzalez, M.A., Gonzalez-Rey, E., Rico, L., Buscher, D., and Delgado, M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60, 1006, 2009.
21. MacDonald, G.I., Augello, A., and De Bari, C. Role of mesenchymal stem cells in reestablishing immunologic tolerance in autoimmune rheumatic diseases. Arthritis Rheum 63, 2547, 2011.
22. Liu, H, Ding J.X., Wang J.C., Wang Y.N., Yang M.D., Zhang Y.B., et al. Remission of collagen-induced arthritis through combination therapy of microfracture and transplantation of thermogel-encapsulated bone marrow mesenchymal stem cells. PLoS One 10, e0120596, 2015.
23. Peeters, C.M., Leijs, M.J., Reijman, M., van Osch, G.J., and Bos, P.K. Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review. Osteoarthritis Cartilage 21, 1465, 2013.
24. Wollheim, F.A., Telhag, H., Henricsson, A., and Geborek, P. Prevention of joint destruction in antigen-induced arthritis. Clin Immunol Immunopathol 70, 19, 1994.
25. Matheu, V., Treschow, A., Teige, I., Navikas, V., and Issazadeh-Navikas, S. Local therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-beta knock-out mice. Respir Res 6, 25, 2005.
26. van den Borne, M.P., Raijmakers, N.J., Vanlauwe, J., Victor, J., de Jong, S.N., Bellemans, J., et al. International Cartilage Repair Society (ICRS) and Oswestry macroscopic cartilage evaluation scores validated for use in Autologous Chondrocyte Implantation (ACI) and microfracture. Osteoarthritis Cartilage 15, 1397, 2007.
27. Zhang, K., Zhang, Y., Yan, S., Gong, L., Wang, J., Chen, X, et al. Repair of an articular cartilage defect using adipose-derived stem cells loaded on a polyelectrolyte complex scaffold based on poly(l-glutamic acid) and chitosan. Acta Biomater 9, 7276, 2013.
28. Cake, M.A, Read, R.A., Guillou, B., and Ghosh, P. Modification of articular cartilage and subchondral bone pathology in an ovine meniscectomy model of osteoarthritis by avocado and soya unsaponifiables (ASU). Osteoarthr Cartilage 8, 404, 2000.
29. Krenn, V., Morawietz, L., Haupl, T., Neidel, J., Petersen, I., and König, A. Grading of chronic synovitis - a histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract 198, 317, 2002.
30. Felson, D.T., Smolen, J.S., Wells, G., Zhang, B., van Tuyl, L.H., Funovits, J., et al. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 70, 404, 2011.
31. Nukavarapu, S.P., and Dorcemus, D.L. Osteochondral tissue engineering: current strategies and challenges. Biotechnol Adv 31, 706, 2013.
32. MacFarlane, R.J., Graham, S.M., Davies, P.S., Korres, N., Tsouchnica, H., Heliotis, et al. Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment. Expert Opin Ther Targets 17, 243, 2013.
33. Zhou, B., Yuan, J.D., Zhou, Y.X., Ghawji, M., Deng, Y.P., Lee, A.J., et al. Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis. Clin Immunol 141, 328, 2011.
34. Choi, J.J., Yoo, S.A., Park, S.J., Kang, Y.J., Kim, W.U., Oh, I.H., et al. Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol 153, 269, 2008.
35. Mor, A., Abramson, S.B., and Pillinger, M.H. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 115, 118, 2005.
36. Fox, D.A. The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum 40, 598, 1997.
37. de Isla, N.G., and Stoltz, J.F. In vitro inhibition of IL-1 beta catabolic effects on cartilage: a mechanism involved on diacerein anti-OA properties. Biorheology 45, 433, 2008.
38. Kim, G.W., Lee, N.R., Pi, R.H., Lim, Y.S., Lee, Y.M., Lee, J.M., et al. IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future. Arch Pharm Res 38, 575, 2015.
39. Kotake, S., and Nanke, Y. Effect of TNF alpha on osteoblastogenesis from mesenchymal stem cells. Biochim Biophys Acta 1840, 1209, 2014.
40. Izquierdo, E., Canete, J.D., Celis, R., Del Rey, M.J., Usategui, A., Marsal, S., et al. Synovial fibroblast hyperplasia in rheumatoid arthritis clinicopathologic correlations and partial reversal by anti-tumor necrosis factor therapy. Arthritis Rheum 63, 2575, 2011.
41. del Rey, M.J., Izquierdo, E., Caja, S., Usategui, A., Santiago, B., Galindo, M., et al. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1alpha/vascular endothelial growth factor-mediated pathway in immunodeficient mice. Arthritis Rheum 60, 2926, 2009.
42. Buckley, C.D., Filer, A., Haworth, O., Parsonage, G., and Salmon, M. Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease. Ann Rheum Dis 63 Suppl 2, ii92, 2004.
43. Skalska, U., Kontny, E., Prochorec-Sobieszek, M., and Maslinski, W. Intra-articular adipose-derived mesenchymal stem cells from rheumatoid arthritis patients maintain the function of chondrogenic differentiation. Rheumatology 51, 1757, 2012.
44. Papadaki, H.A., Kritikos, H.D., Gemetzi, C., Koutala, H., Marsh, J.C., Boumpas, D.T., et al. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect. Blood 99, 1610, 2002.